Alibaba Health Information Technology Limited (HKG:0241)
 5.75
 -0.10 (-1.71%)
  Nov 4, 2025, 11:59 AM HKT
HKG:0241 Cash Flow Statement
Financials in millions CNY. Fiscal year is April - March.
 Millions CNY. Fiscal year is Apr - Mar.
Fiscal Year  | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 | 
|---|---|---|---|---|---|---|
Period Ending  | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 | 
Net Income     | 1,432 | 883.48 | 535.65 | -265.56 | 348.59 | Upgrade   | 
Depreciation & Amortization     | 57.61 | 53.68 | 63.72 | 60.58 | 39.63 | Upgrade   | 
Loss (Gain) From Sale of Assets     | -0.62 | -0.53 | 1.24 | -0.14 | -70.53 | Upgrade   | 
Loss (Gain) From Sale of Investments     | 399.45 | 283.44 | -112.24 | -542.1 | -65.74 | Upgrade   | 
Loss (Gain) on Equity Investments     | 64.66 | 5.93 | -11.38 | 45.62 | 38.41 | Upgrade   | 
Stock-Based Compensation     | 224.54 | 266.06 | 308.89 | 408.1 | 396.96 | Upgrade   | 
Provision & Write-off of Bad Debts     | 6.21 | 5.14 | 1.82 | 0.13 | -0.32 | Upgrade   | 
Other Operating Activities     | -221.26 | -77.36 | 36.11 | 63.63 | -14.16 | Upgrade   | 
Change in Accounts Receivable     | -273.59 | -211.49 | -64.63 | -201.98 | 7.44 | Upgrade   | 
Change in Inventory     | -107.88 | 614.1 | -711.69 | -129.2 | -283.83 | Upgrade   | 
Change in Accounts Payable     | -498.19 | -363.48 | 186.71 | 959.57 | 715.78 | Upgrade   | 
Change in Unearned Revenue     | 140.41 | 59.62 | 234.39 | 70.1 | 19.26 | Upgrade   | 
Change in Other Net Operating Assets     | 171.28 | -436.26 | -212.91 | -44.39 | -122.07 | Upgrade   | 
Operating Cash Flow     | 1,395 | 1,080 | 255.69 | 424.36 | 1,009 | Upgrade   | 
Operating Cash Flow Growth     | 29.19% | 322.32% | -39.75% | -57.96% | 72.96% | Upgrade   | 
Capital Expenditures     | -18.89 | -22.77 | -5.61 | -14.93 | -17.08 | Upgrade   | 
Sale of Property, Plant & Equipment     | 5.97 | 0.75 | 0.41 | 1.86 | 0.82 | Upgrade   | 
Cash Acquisitions     | - | -131.03 | -77.33 | -815.6 | - | Upgrade   | 
Divestitures     | - | - | - | - | -10.61 | Upgrade   | 
Sale (Purchase) of Intangibles     | -0.01 | -0.01 | -0.31 | -0.19 | -0.48 | Upgrade   | 
Investment in Securities     | -2,943 | -4,857 | -512.48 | 2,799 | -4,725 | Upgrade   | 
Other Investing Activities     | 348.79 | 115.89 | 47.08 | -112.09 | -234.53 | Upgrade   | 
Investing Cash Flow     | -2,596 | -4,881 | -532.44 | 1,872 | -4,961 | Upgrade   | 
Long-Term Debt Repaid     | -38.09 | -39.93 | -42.59 | -47.01 | -31.62 | Upgrade   | 
Total Debt Repaid     | -38.09 | -39.93 | -42.59 | -47.01 | -31.62 | Upgrade   | 
Net Debt Issued (Repaid)     | -38.09 | -39.93 | -42.59 | -47.01 | -31.62 | Upgrade   | 
Issuance of Common Stock     | 4.59 | 0.88 | 12.89 | 9.69 | 8,994 | Upgrade   | 
Repurchase of Common Stock     | -39.93 | -104.57 | -81.58 | -16.52 | -39.58 | Upgrade   | 
Other Financing Activities     | 0.92 | -1,839 | - | -4.79 | -0.11 | Upgrade   | 
Financing Cash Flow     | -72.52 | -1,982 | -111.28 | -58.63 | 8,922 | Upgrade   | 
Foreign Exchange Rate Adjustments     | 2.09 | 36.78 | 283.45 | -148.89 | -313.06 | Upgrade   | 
Net Cash Flow     | -1,272 | -5,747 | -104.58 | 2,089 | 4,657 | Upgrade   | 
Free Cash Flow     | 1,376 | 1,057 | 250.08 | 409.43 | 992.35 | Upgrade   | 
Free Cash Flow Growth     | 30.19% | 322.69% | -38.92% | -58.74% | 72.27% | Upgrade   | 
Free Cash Flow Margin     | 4.50% | 3.91% | 0.93% | 1.99% | 6.40% | Upgrade   | 
Free Cash Flow Per Share     | 0.09 | 0.07 | 0.02 | 0.03 | 0.07 | Upgrade   | 
Cash Interest Paid     | 2.61 | 5.97 | 5.83 | 3.82 | 2.45 | Upgrade   | 
Cash Income Tax Paid     | 106.93 | 40.61 | 43.11 | 45.34 | 27.9 | Upgrade   | 
Levered Free Cash Flow     | 693.23 | 318.76 | -19.58 | 700.89 | 696.15 | Upgrade   | 
Unlevered Free Cash Flow     | 694.86 | 322.49 | -15.93 | 703.27 | 697.68 | Upgrade   | 
Change in Working Capital     | -567.97 | -337.52 | -568.13 | 654.1 | 336.59 | Upgrade   | 
Source: S&P Global Market Intelligence. Standard template. Financial Sources.